Chang‐En Yu

11.3k total citations · 1 hit paper
30 papers, 1.5k citations indexed

About

Chang‐En Yu is a scholar working on Molecular Biology, Physiology and Genetics. According to data from OpenAlex, Chang‐En Yu has authored 30 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 17 papers in Physiology and 10 papers in Genetics. Recurrent topics in Chang‐En Yu's work include Alzheimer's disease research and treatments (15 papers), Dementia and Cognitive Impairment Research (6 papers) and Epigenetics and DNA Methylation (5 papers). Chang‐En Yu is often cited by papers focused on Alzheimer's disease research and treatments (15 papers), Dementia and Cognitive Impairment Research (6 papers) and Epigenetics and DNA Methylation (5 papers). Chang‐En Yu collaborates with scholars based in United States, Nigeria and Denmark. Chang‐En Yu's co-authors include Lynn M. Bekris, Debby W. Tsuang, Thomas D. Bird, Sunny Chen, Gerard D. Schellenberg, Lesley Leong, C. Dirk Keene, Steven P. Millard, Zachary Thomson and Lynn M. Bekris and has published in prestigious journals such as PLoS ONE, Annals of Neurology and Brain Research.

In The Last Decade

Chang‐En Yu

30 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Review Article: Genetics of Alzheimer Disease

2010 683 citations Lynn M. Bekris, Chang‐En Yu et al. profile →

Peers

Countries citing papers authored by Chang‐En Yu

Since Specialization

Citations

This map shows the geographic impact of Chang‐En Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang‐En Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang‐En Yu more than expected).

Fields of papers citing papers by Chang‐En Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chang‐En Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang‐En Yu. The network helps show where Chang‐En Yu may publish in the future.

Co-authorship network of co-authors of Chang‐En Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Chang‐En Yu. A scholar is included among the top collaborators of Chang‐En Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chang‐En Yu. Chang‐En Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	APOE Locus-Associated Mitochondrial Function and Its Implication in Alzheimer’s Disease and Aging 2023 ·International Journal of Molecular Sciences ·(unknown), Lesley Leong, Sunny Chen, (unknown), Chang‐En Yu	8
2	Weight Loss Is a Strong Predictor of Memory Disorder Independent of Genetic Influences 2023 ·Genes ·Sunny Chen, Sara M. Sarasua, (unknown), Jane M. DeLuca, Stephen Thielke, Chang‐En Yu	1
3	A Preliminary Comparison of the Methylome and Transcriptome from the Prefrontal Cortex Across Alzheimer’s Disease and Lewy Body Dementia 2023 ·Journal of Alzheimer s Disease Reports ·Daniel Fisher, (unknown), Chang‐En Yu, Debby W. Tsuang	6
4	TOMM40 genetic variants associated with healthy aging and longevity: a systematic review 2022 ·BMC Geriatrics ·Sunny Chen, Sara M. Sarasua, (unknown), Jane M. DeLuca, Luigi Boccuto, Stephen Thielke, Chang‐En Yu	14
5	TOMM40 RNA Transcription in Alzheimer’s Disease Brain and Its Implication in Mitochondrial Dysfunction 2021 ·Genes ·(unknown), Sunny Chen, Lesley Leong, (unknown), Chang‐En Yu	27
6	Redefining transcriptional regulation of the APOE gene and its association with Alzheimer’s disease 2020 ·PLoS ONE ·(unknown), (unknown), Sunny Chen, Lesley Leong, Aleen D. Saxton, Brian C. Kraemer, Martin Darvas, C. Dirk Keene, Andrew Shutes‐David, (unknown), (unknown), Chang‐En Yu	35
7	Lack of APOE Christchurch variant in five age of onset outliers with PSEN1, PSEN2 Alzheimer's disease and MAPT frontotemporal dementia 2020 ·Journal of the Neurological Sciences ·Chang‐En Yu, Sunny Chen, Suman Jayadev, Thomas D. Bird	2
8	Association of Uncommon, Noncoding Variants in the APOE Region With Risk of Alzheimer Disease in Adults of European Ancestry 2020 ·JAMA Network Open ·Elizabeth Blue, Anqi Cheng, Sunny Chen, Chang‐En Yu	10
9	Evolution of a Human-Specific Tandem Repeat Associated with ALS 2020 ·The American Journal of Human Genetics ·(unknown), Kathryn Gudsnuk, Samuel N. Smukowski, (unknown), (unknown), Jay P. Ross, Arvis Sulovari, Cynthia V. Bourassa, Dan Spiegelman, Julien Couthouis, Chang‐En Yu, Debby W. Tsuang, Suman Jayadev, Mark A. Kay, Aaron D. Gitler, Nicolas Dupré, Evan E. Eichler, Patrick A. Dion, Guy A. Rouleau, Paul N. Valdmanis	35
10	Glia-specific APOE epigenetic changes in the Alzheimer’s disease brain 2018 ·Brain Research ·(unknown), Lesley Leong, Zachary Thomson, Sunny Chen, (unknown), C. Dirk Keene, Steven P. Millard, Chang‐En Yu	40
11	APOE DNA methylation is altered in Lewy body dementia 2018 ·Alzheimer s & Dementia ·(unknown), Lesley Leong, Sunny Chen, C. Dirk Keene, Steven P. Millard, Andrew Shutes‐David, Oscar L. López, Julia Kofler, Jeffrey Kaye, Randy Woltjer, Peter T. Nelson, Janna H. Neltner, Gregory A. Jicha, Douglas Galasko, Eliezer Masliah, James B. Leverenz, Chang‐En Yu, Debby W. Tsuang	22
12	DNA methylation of TOMM40-APOE-APOC2 in Alzheimer’s disease 2018 ·Journal of Human Genetics ·Yvonne Shao, McKenzie Shaw, (unknown), Maria Khrestian, (unknown), Pene J. Barnard, (unknown), Jagan A. Pillai, Chang‐En Yu, C. Dirk Keene, James B. Leverenz, Lynn M. Bekris	56
13	TOMM40 intron 6 poly‐T length, age at onset, and neuropathology of AD in individuals with APOE ɛ3/ɛ3 2012 ·Alzheimer s & Dementia ·Ge Li, Lynn M. Bekris, Lesley Leong, Ellen J. Steinbart, Jane B. Shofer, Paul K. Crane, Eric B. Larson, Elaine R. Peskind, Thomas D. Bird, Chang‐En Yu	25
14	Tau phosphorylation pathway genes and cerebrospinal fluid tau levels in Alzheimer's disease 2012 ·American Journal of Medical Genetics Part B Neuropsychiatric Genetics ·Lynn M. Bekris, (unknown), (unknown), Gail Li, Doug Galasko, Martin R. Farlow, Joseph F. Quinn, Jeffrey Kaye, James B. Leverenz, Debby W. Tsuang, Chang‐En Yu, Elaine R. Peskind	14
15	Amyloid precursor protein (APP) processing genes and cerebrospinal fluid APP cleavage product levels in Alzheimer's disease 2011 ·Neurobiology of Aging ·Lynn M. Bekris, (unknown), Steven P. Millard, David J. Lockhart, (unknown), Douglas Galasko, Martin R. Farlow, Chris M. Clark, Joseph F. Quinn, Jeffrey Kaye, Gerald D. Schellenberg, James B. Leverenz, Peter Seubert, Debby W. Tsuang, Elaine R. Peskind, Chang‐En Yu	45
16	Evidence for three loci modifying age‐at‐onset of Alzheimer's disease in early‐onset PSEN2 families 2010 ·American Journal of Medical Genetics Part B Neuropsychiatric Genetics ·Elizabeth E. Marchani, Thomas D. Bird, Ellen J. Steinbart, Elisabeth A. Rosenthal, Chang‐En Yu, Gerard D. Schellenberg, Ellen M. Wijsman	19
17	Heterozygous parkin point mutations are as common in control subjects as in Parkinson's patients 2006 ·Annals of Neurology ·Denise M. Kay, Dawn M. Moran, Lina Moses, Parvoneh Poorkaj, Cyrus P. Zabetian, John G. Nutt, Stewart A. Factor, Chang‐En Yu, Jennifer S. Montimurro, Robert G. Keefe, Gerard D. Schellenberg, Haydeh Payami	80
18	ADLAPH: A molecular haplotyping method based on allele-discriminating long-range PCR 2004 ·Genomics ·Chang‐En Yu, Bernie Devlin, (unknown), (unknown), Gerard D. Schellenberg	18
19	Modest evidence for linkage and possible confirmation of association between NOTCH4 and schizophrenia in a large veterans affairs cooperative study sample 2002 ·American Journal of Medical Genetics Part B Neuropsychiatric Genetics ·Andrew D. Skol, Keith A. Young, Debby W. Tsuang, Stephen V. Faraone, (unknown), S Bingham, (unknown), (unknown), (unknown), Chang‐En Yu, (unknown), John Pepple, (unknown), (unknown), David M. Weiss, Joseph F. Collins, Tim P. Keith, Michael Boehnke, Gerald D. Schellenberg, Ming T. Tsuang	27
20	Apolipoprotein E genotypes in Parkinson's disease with and without dementia 1995 ·Annals of Neurology ·William C. Koller, Sander L. Glatt, Jean Hubble, Anthony M. Paolo, Alexander I. Tröster, Karen Schmidt, (unknown), Michael Handler, Rebecca T. Horvat, Coleman Martin, Ellen M. Wijsman, Chang‐En Yu, Gerard D. Schellenberg	69

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact